Mallinckrodt M&A Summary
Mallinckrodt has acquired 16 companies, including 1 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 7 assets.
Mallinckrodt’s largest acquisition to date was in 2014, when it acquired Questcor Pharmaceuticals for $5.8B. It’s largest disclosed sale occurred in 2024, when it sold Therakos to CVC Capital Partners for $925M. Mallinckrodt has acquired in 8 different US states, and 3 countries. The Company’s most targeted sectors include life science (70%) and medical products (31%).
M&A Summary
-
M&A Total Activity20
- M&A Buy Activity13
- M&A Sell Activity7
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 14
Unlimited Searches
